Updates in the Treatment of Metastatic Colorectal Cancer

Phoenix, AZ US
November 6, 2015

Learning Objectives

  • Restate the current standard of care options for the first-line mCRC therapy, using chemotherapy in combination with targeted agents
  • Identify which patients should undergo mutation testing, and understand how these results impact selection of therapy
  • Assess the potential utility of other predictive biomarkers
  • Update the incorporation of biologics into the management of colorectal cancer
  • Discuss indications for and potential benefits of radiation therapy in patients with unresectable disease
  • Compare the potential benefits and limitation of oral cancer therapy for mCRC
Course summary
Available credit: 
  • 1.00 AANP
  • 0.83 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC
Course opens: 
11/06/2015
Course expires: 
03/31/2016
Event starts: 
11/06/2015 - 3:30pm
Event ends: 
11/06/2015 - 4:30pm
Cost:
$0.00
Parent activity set: 
Rating: 
0
JW Marriott Desert Ridge
5350 East Marriott Drive
Phoenix, AZ 85054
United States

John Marshall, MD
Robin Sommers, NP, DNP, ANP-BC, AONCP

Available Credit

  • 1.00 AANP
  • 0.83 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.